Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 1

Status

Completed 6Terminated 1

Sponsor Class

OTHER 29NIH 19NETWORK 7INDUSTRY 5

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7

Conditions

Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 24Burkitt Lymphoma 14Leukemia, Biphenotypic, Acute 10Urinary Bladder Neoplasms 7Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Dendritic Cell Sarcoma, Interdigitating 4Urethral Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Sarcoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Medulloblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Promyelocytic, Acute 2

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Methotrexate × Clear all
NCT00036868 2024-03-08

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
90 enrolled
Breast

Breast Neoplasms

NCT00309478 2023-06-29

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Austrian Breast & Colorectal Cancer Study Group

Phase 3 Completed
1,099 enrolled
Breast

Breast Neoplasms

NCT00296010 2021-02-23

CASA

ETOP IBCSG Partners Foundation

Phase 3 Terminated
77 enrolled
Breast

Breast Neoplasms

NCT00309569 2020-10-14

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Austrian Breast & Colorectal Cancer Study Group

Phase 3 Completed
429 enrolled
Breast

Breast Neoplasms

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
672 enrolled
Breast

Breast Neoplasms

NCT00022516 2016-09-16

22-00

ETOP IBCSG Partners Foundation

Phase 3 Completed
1,086 enrolled 10 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00002784 2013-04-04

15-95

ETOP IBCSG Partners Foundation

Phase 3 Completed
344 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡